Nanobiotechnology are materials with a particle size of between 1 and 100 nanometers. They are used in a wide variety of applications, from medical and scientific research to consumer products. The use of Nanobiotechnology has the potential to bring about significant environmental, economic and social benefits. However, the potential risks associated with Nanobiotechnology must also be taken into consideration. In order to ensure that Nanobiotechnology are used responsibly and sustainably, it is important to consider their impacts on the environment, human health, and the economy. A comprehensive approach to understanding and managing the potential risks associated with Nanobiotechnology is essential. This includes identifying potential risks and hazards, assessing potential impacts, and developing strategies to minimize those impacts. In order to ensure the safe and sustainable use of Nanobiotechnology, research and development should focus on the development of safer, more efficient and cost-effective Nanobiotechnology and nanotechnologies. It is also important to consider the social impacts of Nanobiotechnology and to ensure that any new Nanobiotechnology are used in an ethical and responsible manner.
Title : 40,000 implants in humans and no failure: The impact of nanomedicine
Thomas J Webster, Hebei University of Technology, China
Title : Cellulose-derived biochar modified with iron oxide and ZnO nanoparticles by a novel one-step pyrolytic method for removal of emerging contaminants from water
Rashad Al Gaashani, Hamad Bin Khalifa University, Qatar
Title : Harnessing the unique properties of engineered nanostructures for sensing
Harry Ruda, University of Toronto, Canada
Title : Circumventing challenges in developing CVD graphene on steels for extraordinary and durable corrosion resistance
Raman Singh, Monash University, Australia
Title : Nano DAP augments productivity, phosphorus use efficiency, and profitability of spring wheat in India
Binaya Kumar Parida, Coromandel International Ltd, India
Title : Lipid nanoparticles formulations: From bench scale to industrial scale
Mohammad A Obeid, RAK Medical and Health Sciences University, United Arab Emirates